Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Jones, Suzanne F.
6480  Ergebnisse:
Personensuche X
?
1

A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topote..:

Johnson, Melissa L ; Patel, Manish R ; Aljumaily, Raid...
The Oncologist.  28 (2023)  7 - p. 640-e559 , 2023
Link: https://doi.org/10.1093/..
 
?
2

Discordance in Tumor Mutation Burden from Blood and Tissue ..:

Sturgill, Emma G ; Misch, Amanda ; Jones, Carissa C...
The Oncologist.  27 (2022)  3 - p. 175-182 , 2022
Link: https://doi.org/10.1093/..
 
?
3

A Randomized, Double-Blinded, Phase II Trial of Carboplatin..:

Spigel, David R. ; Shipley, Dianna L. ; Waterhouse, David M....
The Oncologist.  24 (2019)  12 - p. e1409-e1416 , 2019
Link: https://doi.org/10.1634/..
 
?
4

A phase I dose escalation study of NK012, an SN-38 incorpor..:

Burris, Howard A. ; Infante, Jeffrey R. ; Anthony Greco, F....
Cancer Chemotherapy and Pharmacology.  77 (2016)  5 - p. 1079-1086 , 2016
Link: https://doi.org/10.1007/..
 
?
5

A first-in-human phase I study of the oral Notch inhibitor,..:

Pant, Shubham ; Jones, Suzanne F. ; Kurkjian, Carla D....
European Journal of Cancer.  56 (2016)  - p. 1-9 , 2016
Link: https://doi.org/10.1016/..
 
?
6

Safety and activity of IT-139, a ruthenium-based compound, ..:

Burris, Howard A. ; Bakewell, Suzanne ; Bendell, Johanna C....
ESMO Open.  1 (2016)  6 - p. e000154 , 2016
Link: https://doi.org/10.1136/..
 
?
7

A phase 1 study of the sachet formulation of the oral dual ..:

Bendell, Johanna C. ; Kurkjian, Carla ; Infante, Jeffrey R....
Investigational New Drugs.  33 (2015)  2 - p. 463-471 , 2015
Link: https://doi.org/10.1007/..
 
?
8

A phase I study of VS-6063, a second-generation focal adhes..:

Jones, Suzanne F. ; Siu, Lillian L. ; Bendell, Johanna C....
Investigational New Drugs.  33 (2015)  5 - p. 1100-1107 , 2015
Link: https://doi.org/10.1007/..
 
?
9

Evaluation of CYP3A‐mediated drug–drug interactions with ro..:

Laille, Eric ; Patel, Manish ; Jones, Suzanne F....
The Journal of Clinical Pharmacology.  55 (2015)  12 - p. 1378-1385 , 2015
Link: https://doi.org/10.1002/..
 
?
10

A first-in-human phase I dose-escalation, pharmacokinetic, ..:

Gray, Jhanelle E. ; Infante, Jeffrey R. ; Brail, Les H....
Investigational New Drugs.  33 (2015)  6 - p. 1187-1196 , 2015
Link: https://doi.org/10.1007/..
 
?
11

Phase 1, open-label, dose-escalation, and pharmacokinetic s..:

Bendell, Johanna C. ; Hong, David S. ; Burris III, Howard A....
Cancer Chemotherapy and Pharmacology.  74 (2014)  1 - p. 125-130 , 2014
Link: https://doi.org/10.1007/..
 
?
12

Phase 1, open‐label, dose escalation, safety, and pharmacok..:

Bendell, Johanna C. ; Patel, Manish R. ; Infante, Jeffrey R....
Cancer.  121 (2014)  7 - p. 1056-1063 , 2014
Link: https://doi.org/10.1002/..
 
?
13

A phase Ib study of linsitinib (OSI-906), a dual inhibitor ..:

Bendell, Johanna C. ; Jones, Suzanne F. ; Hart, Lowell...
Investigational New Drugs.  33 (2014)  1 - p. 187-193 , 2014
Link: https://doi.org/10.1007/..
 
?
14

A phase 1b study of trametinib, an oral Mitogen-activated p..:

Infante, Jeffrey R. ; Papadopoulos, Kyriakos P. ; Bendell, Johanna C....
European Journal of Cancer.  49 (2013)  9 - p. 2077-2085 , 2013
Link: https://doi.org/10.1016/..
 
?
15

Safety, pharmacokinetics and pharmacodynamics of the anti-A..:

Infante, Jeffrey R. ; Bendell, Johanna C. ; Goff, Laura Williams...
European Journal of Cancer.  49 (2013)  6 - p. 1169-1175 , 2013
Link: https://doi.org/10.1016/..
 
1-15